Showing posts from September, 2018

Big deal for small cells.

ALTArnative ALK-inhibitor.

Screen right.


More PACIFIC results.

I squam, you squam.

Caught on camera.

Daniel downer.

Same ol’ story.



If it suits you.

Bounce with me, bounce with me.

Ew in?

Another pembro punch.

Time’s up.

Colonial cancer.

Long enough.


White out.

Be specific.

Quantity over quality.

Go viral.

Health insurance.

More certain.

Hot topic.

V-ery useful.

Take that, rewind it back.

Tailoring indications.

Staying relevant.

Problems STEM from early differences.


Jacob’s ladder.

Registry game strong.

Proton PR.

Temper hope with honesty.

Axe the ax dissection.

Use your whole brain.

Cautionary tale.

Got milk?

Targeted takeover.

Targeted timeout.

Too much too late.

Worse late than never.

Screen shot.

High quality.

Wait right there.


Sequential victories.

Lace up.

Das right.

Back to nature.

Second time’s a charm.

Who watches the Watchmen?

Along came polyamines.

Control yo’self.

New-age AURA.

Cut it out.

Rethinking reconstruction.

None of the above.